Literature DB >> 29794344

Performance of marrow stromal cell-seeded small-caliber multilayered vascular graft in a senescent sheep model.

Krishna Madhavan1, Winston Elliot, Yan Tan, Eric Monnet, Wei Tan.   

Abstract

Failure of small-caliber grafts, used as bypass or reconstructive grafts in cardiovascular treatments, is often caused by thrombosis and stenosis. We have developed a multilayered, compliant graft with an electrospun heparin-encapsulated core and collagen-chitosan shell. Herein, the performances of acellular and cell-seeded grafts were evaluated in adult sheep for preclinical assessment. Allogeneic ovine marrow stroma cells (MSCs) were uniformly attached to the lumen of cell-seeded grafts. Interposition grafts were used for carotid arteries. Four grafts were tested for each type. Upon implantation, all grafts successfully restored perfusion and rhythmically deformed under pulsatile arterial flow. Weekly ultrasonography and Doppler revealed that all grafts remained patent for perfusion during the course of one-month study. No formation of blood clots or other complications were found. The diameter of graft lumen did not vary significantly over the time or with the graft type, while narrowing at anastomosis and significant thickening of graft wall were found in both types of grafts. More significant neotissue formation was found at anastomotic sections of acellular controls compared to cell-seeded grafts. Results from histological and immunofluorescent analyses revealed moderate intimal hyperplasia (IH) at anastomosis. When compared to cell-seeded grafts, acellular controls presented thicker IH composed of α-smooth muscle actin positive cells and ground substances, which correlated with reduced and more disturbing flow. IH was thickest at anastomosis and tapered off to a minimum in the mid-section. Few PECAM-positive cells appeared on cell-seeded grafts but not acellular controls. Additionally, lesser graft thickening was found in cell-seed grafts, which might be associated with the function of stromal cells in altering the fibrotic process during tissue repair. Results suggest that MSCs held the potential to reduce hyperplasia and improve healing in an aged, large animal model for vascular grafting.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29794344     DOI: 10.1088/1748-605X/aac7a6

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  2 in total

1.  Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.

Authors:  Cameron A Best; Jason M Szafron; Kevin A Rocco; Jacob Zbinden; Ethan W Dean; Mark W Maxfield; Hirotsugu Kurobe; Shuhei Tara; Paul S Bagi; Brooks V Udelsman; Ramak Khosravi; Tai Yi; Toshiharu Shinoka; Jay D Humphrey; Christopher K Breuer
Journal:  Acta Biomater       Date:  2019-06-12       Impact factor: 8.947

2.  Effects of recipient age, heparin release and allogeneic bone marrow-derived stromal cells on vascular graft remodeling.

Authors:  Richard Johnson; Michael Rafuse; Prakash Parthiban Selvakumar; Wei Tan
Journal:  Acta Biomater       Date:  2021-02-24       Impact factor: 8.947

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.